drugset / Trial / NCT04785027

Comparison of PSORI-CM01 Formula vs Gu Ben Hua Yu Formula Combined With AD-MSCs in Psoriasis

NCT04785027

RandomizedParallel-groupOpen-labelTreatment

Summary

The purpose of this study is to evaluate and compare the safety and efficacy of PSORI-CM01 formula vs Gu Ben Hua Yu formula combined with Expanded Allogeneic AD-MSCs in patients with moderate to severe psoriasis. And it explores the expectations of patients for the treatment of traditional Chinese medicine combined with stem cells and their expectations to participate in this study. The trial would provide preliminary data for large sample clinical randomized controlled trials.

Timeline

Start
2021-03-17
Primary completion
2021-06-17
Completion
2024-09-30

Drugs

EvaluationDrugModalityDoseRoute
Subject Autologous Adipose-Derived Mesenchymal Stromal Cells Cell therapy 2e+06 cells/kg Intravenous
Subject Chinese herbal medicine Traditional medicine (herbal / TCM) Oral
Subject PSORI-CM01 formula Unknown Oral

Indications